Steven E. Diamond, PhD Chief Scientific
Officer
Dr. Diamond joined Magellan in August 2007 to help the company
leverage its existing technologies and development capabilities across the
company. His charge is to help define and implement Magellan’s
diagnostic-product portfolio strategy – providing scientific expertise and
leadership to help ensure that its product pipeline is compelling, high quality,
and delivered in a timely manner to meet market needs. His input is also
critical in Magellan’s acquisition, licensing, and partnership strategy – where
he provides scientific evaluation and counsel in the company’s pursuit of
complementary technologies that expand its presence in the point-of-care and
hospital-laboratory segments.
Dr. Diamond came to Magellan from Siemens Medical Solutions Diagnostics
(formerly Bayer Diagnostics), where he was vice president, research and
development, for the point-of-care product lines: urinalysis, blood gas, and
HbA1c (diabetes testing). In addition to internal product development, Dr.
Diamond had an active role in the evaluation and development of external
technologies to enhance and extend the company’s products for near-patient
testing. Under his stewardship, Bayer successfully developed and launched a
suite of market-leading products for near-patient testing.
Dr. Diamond previously held several senior-level positions at Bayer
Diagnostics. From 2000-2004, he was vice president research and development for
the near-patient-testing segment. Before that, he was vice president, research
and development for the self-testing segment. Prior to joining Bayer, he was
vice president, research and development for the Stratus Immunochemistry
business of Baxter Diagnostics. Dr. Diamond received a bachelor’s degree cum
laude in chemistry from Rensselaer Polytechnic Institute (Troy, New York)
and a PhD in chemistry from Stanford University (Stanford, California), with
Nobel Laureate, Professor Henry Taube, as his research advisor. He is the
recipient of several honors and awards, has authored many technical publications
and abstracts in peer-reviewed journals, and is the co-holder of numerous United
States and international patents. |